Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Exp Eye Res. 2014 Feb 26;121:35–40. doi: 10.1016/j.exer.2014.02.013

Table 2.

Anova p-value comparisons of myofibroblasts in different treatment groups

SMA+ cells SMA+GFP+cells SMA+GFP-cells
Empty pGFPC1 vector vs. untreated control 1.00 1.00 1.00
Empty pCMV vector vs. untreated control 0.04 1.0 0.90
pGFPC1.TGFRBKDEL vector vs. untreated control <0.001 <0.01 <0.01
pCMV.PDGFRB.23KDEL vector vs. untreated control <0.01 <0.01 <0.01
Empty pCMV vector vs. empty pGFPC1 vector 1.00 0.92 1.00
pGFPC1.TGFRBKDEL vector vs. empty pGFPC1 vector <0.001 <0.01 <0.01
pCMV.PDGFRB.23KDEL vector vs. empty pGFPC1 vector <0.01 0.03 <0.01
pGFPC1.TGFRBKDEL vector vs. empty pCMV vector <0.001 <0.01 <0.01
pCMV.PDGFRB.23KDEL vector vs. empty pCMV vector <0.001 <0.01 <0.01
pGFPC1.TGFRBKDEL vector vs. pCMV.PDGFRB.23KDEL vector <0.01 0.24 0.28